Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MGNX MacroGenics, Inc.
$2.76 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MGNX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 175.4M
Enterprise value 33.1M
Trailing PE 25.320988
Forward PE -3.0206184
PEG Ratio -3.0206184
Enterprise to EBITDA -0.504
Enterprise to revenue 0.221
Price to book MRQ 3.3371298
Price to sales TTM 1.2456094

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 149.5M
EBITDA -65669000
Diluted EPS TTM -1.18
Total Cash (MRQ) 189.9M
Current ratio (MRQ) 5.101
Operating Cash Flow (TTM) -81040000

MGNX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MGNX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.